Chen C - Search Results

1

Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit.

Trinkaus MA, Lapinsky SE, Crump M, Keating A, Reece DE, Chen C, Hallett DC, Franke N, Winter A, Mikhael JR. Trinkaus MA, et al. Among authors: chen c. Bone Marrow Transplant. 2009 Mar;43(5):411-5. doi: 10.1038/bmt.2008.336. Epub 2008 Oct 20. Bone Marrow Transplant. 2009. PMID: 18936734

2

Intensification of the stem cell transplant induction regimen results in increased treatment-related mortality without improved outcome in multiple myeloma.

Abraham R, Chen C, Tsang R, Simpson D, Murray C, Davidson M, Meharchand J, Sutton DM, Crump RM, Keating A, Stewart AK. Abraham R, et al. Among authors: chen c. Bone Marrow Transplant. 1999 Dec;24(12):1291-7. doi: 10.1038/sj.bmt.1702060. Bone Marrow Transplant. 1999. PMID: 10627637 Clinical Trial.

3

Beyond bone marrow: a new source of stem cells.

Chen CI, Keating A. Chen CI, et al. CMAJ. 2001 Mar 6;164(5):683. CMAJ. 2001. PMID: 11258225 Free PMC article. No abstract available.

4

Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes.

Chen CI, Abraham R, Tsang R, Crump M, Keating A, Stewart AK. Chen CI, et al. Bone Marrow Transplant. 2001 Jan;27(2):177-82. doi: 10.1038/sj.bmt.1702771. Bone Marrow Transplant. 2001. PMID: 11281387

5

Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma.

Chen CI, Crump M, Tsang R, Stewart AK, Keating A. Chen CI, et al. Br J Haematol. 2001 Apr;113(1):202-8. doi: 10.1046/j.1365-2141.2001.02705.x. Br J Haematol. 2001. PMID: 11328303 Free article.

6

'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.

Chen CI, Roitman D, Tsang R, Stewart AK, Keating A, Crump M. Chen CI, et al. Bone Marrow Transplant. 2002 Dec;30(12):885-91. doi: 10.1038/sj.bmt.1703772. Bone Marrow Transplant. 2002. PMID: 12476281

7

Intermediate dose thalidomide (200 mg daily) has comparable efficacy and less toxicity than higher doses in relapsed multiple myeloma.

Wechalekar AD, Chen CI, Sutton D, Reece D, Voralia M, Stewart AK. Wechalekar AD, et al. Among authors: chen ci. Leuk Lymphoma. 2003 Jul;44(7):1147-9. doi: 10.1080/1042819031000067918. Leuk Lymphoma. 2003. PMID: 12916866 Review.

8

Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome.

Mollee PN, Wechalekar AD, Pereira DL, Franke N, Reece D, Chen C, Stewart AK. Mollee PN, et al. Among authors: chen c. Bone Marrow Transplant. 2004 Feb;33(3):271-7. doi: 10.1038/sj.bmt.1704344. Bone Marrow Transplant. 2004. PMID: 14647248

9

The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant.

Chang H, Sloan S, Li D, Zhuang L, Yi QL, Chen CI, Reece D, Chun K, Keith Stewart A. Chang H, et al. Br J Haematol. 2004 Apr;125(1):64-8. doi: 10.1111/j.1365-2141.2004.04867.x. Br J Haematol. 2004. PMID: 15015970 Free article.

10

IgD multiple myeloma--a clinical profile and outcome with chemotherapy and autologous stem cell transplantation.

Wechalekar A, Amato D, Chen C, Keith Stewart A, Reece D. Wechalekar A, et al. Among authors: chen c. Ann Hematol. 2005 Feb;84(2):115-7. doi: 10.1007/s00277-004-0944-x. Epub 2004 Oct 22. Ann Hematol. 2005. PMID: 15503021

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90,723 results

Search Page

Filters